As shown in Table 1, median GH and IGF-I levels documented at the time of diagnosis were significantly higher in Group 2 (p?<?0.05 vs. Group 1), but the frequencies of hypopituitarism in the two groups were similar. This evidence concerns the gene IGF1 and hypopituitarism.